Epizyme Statistics
Share Statistics
Epizyme has 0
shares outstanding. The number of shares has increased by 61.68%
in one year.
| n/a |
| 61.68% |
| 61.68% |
| n/a |
| 135.37M |
| n/a |
| n/a |
Short Selling Information
The latest short interest is 2.34M, so 0% of the outstanding
shares have been sold short.
| 2.34M |
| n/a |
| n/a |
| 1.21 |
Valuation Ratios
The PE ratio is -1.01 and the forward
PE ratio is null.
Epizyme's PEG ratio is
-0.12.
| -1.01 |
| n/a |
| 6.74 |
| n/a |
| -12.2 |
| -1.11 |
| -0.12 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Epizyme.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.56,
with a Debt / Equity ratio of -11.56.
| 4.56 |
| 4.49 |
| -11.56 |
| -1.08 |
| -1.05 |
| -9.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $149.71K |
| $-1M |
| 250 |
| 0.13 |
| 3.26 |
Taxes
| 22K |
| -0.01% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is -0.42, so Epizyme's
price volatility has been lower than the market average.
| -0.42 |
| n/a |
| 1.21 |
| n/a |
| 61.3 |
| 4,181,034 |
Income Statement
In the last 12 months, Epizyme had revenue of 37.43M
and earned -251.12M
in profits. Earnings per share was -2.49.
| 37.43M |
| 26.93M |
| -226.94M |
| -251.12M |
| -221.69M |
| -215.88M |
| -2.49 |
Full Income Statement Balance Sheet
The company has 98.34M in cash and 239.11M in
debt, giving a net cash position of -140.78M.
| 98.34M |
| 239.11M |
| -140.78M |
| -1.24B |
| n/a |
| n/a |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -226.85M
and capital expenditures -486K, giving a free cash flow of -227.34M.
| -226.85M |
| -486K |
| -227.34M |
| -2.25 |
Full Cash Flow Statement Margins
Gross margin is 71.95%, with operating and profit margins of -606.35% and -670.96%.
| 71.95% |
| -606.35% |
| -670.91% |
| -670.96% |
| -592.33% |
| -606.35% |
| -607.42% |